Mustafa Qadir Hameed, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Excitatory Amino Acid Transporter 2 | 4 | 2023 | 89 | 1.660 |
Why?
|
| Epilepsy, Post-Traumatic | 3 | 2024 | 40 | 1.560 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2020 | 188 | 1.260 |
Why?
|
| Equipment Failure | 2 | 2020 | 578 | 1.160 |
Why?
|
| Ceftriaxone | 4 | 2024 | 175 | 0.990 |
Why?
|
| Interneurons | 4 | 2023 | 593 | 0.870 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2023 | 85 | 0.830 |
Why?
|
| Acetylcysteine | 2 | 2023 | 260 | 0.810 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2019 | 62 | 0.650 |
Why?
|
| Anticonvulsants | 2 | 2024 | 1903 | 0.560 |
Why?
|
| Epilepsy | 5 | 2023 | 3286 | 0.520 |
Why?
|
| Parvalbumins | 4 | 2023 | 261 | 0.510 |
Why?
|
| Percussion | 1 | 2014 | 18 | 0.470 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2020 | 1471 | 0.380 |
Why?
|
| Seizures | 6 | 2023 | 2956 | 0.300 |
Why?
|
| Brain Injuries | 3 | 2014 | 2049 | 0.300 |
Why?
|
| Hydrocephalus | 3 | 2020 | 764 | 0.260 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2024 | 8163 | 0.230 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 2023 | 39 | 0.220 |
Why?
|
| Oxidative Stress | 4 | 2023 | 3108 | 0.220 |
Why?
|
| Rats | 6 | 2024 | 23712 | 0.210 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 18216 | 0.210 |
Why?
|
| Cerebral Ventricles | 2 | 2016 | 542 | 0.210 |
Why?
|
| Glutamic Acid | 2 | 2020 | 1175 | 0.200 |
Why?
|
| Motor Cortex | 2 | 2020 | 1003 | 0.200 |
Why?
|
| Rats, Long-Evans | 4 | 2017 | 382 | 0.200 |
Why?
|
| Pediatrics | 1 | 2017 | 3593 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7424 | 0.190 |
Why?
|
| GABA Agents | 1 | 2020 | 41 | 0.180 |
Why?
|
| Animals | 18 | 2024 | 168253 | 0.160 |
Why?
|
| Postoperative Complications | 1 | 2020 | 15627 | 0.150 |
Why?
|
| Anesthetics, Intravenous | 1 | 2020 | 396 | 0.140 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 464 | 0.140 |
Why?
|
| Tuberous Sclerosis | 1 | 2023 | 1030 | 0.120 |
Why?
|
| Synaptosomes | 1 | 2015 | 116 | 0.120 |
Why?
|
| Electromyography | 1 | 2020 | 1392 | 0.120 |
Why?
|
| Drug Therapy, Combination | 1 | 2024 | 6297 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2020 | 1135 | 0.120 |
Why?
|
| Fluoresceins | 1 | 2014 | 235 | 0.110 |
Why?
|
| Propofol | 1 | 2020 | 603 | 0.110 |
Why?
|
| Tourette Syndrome | 1 | 2017 | 395 | 0.110 |
Why?
|
| Neural Inhibition | 1 | 2017 | 589 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2016 | 3486 | 0.110 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 282 | 0.110 |
Why?
|
| Ependyma | 1 | 2013 | 56 | 0.110 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 957 | 0.110 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 609 | 0.110 |
Why?
|
| Temperature | 1 | 2019 | 2228 | 0.100 |
Why?
|
| Gliosis | 1 | 2013 | 244 | 0.100 |
Why?
|
| Cerebral Palsy | 1 | 2017 | 473 | 0.100 |
Why?
|
| Antioxidants | 1 | 2020 | 1670 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 586 | 0.100 |
Why?
|
| Action Potentials | 1 | 2018 | 1830 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1588 | 0.090 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 599 | 0.090 |
Why?
|
| Male | 16 | 2024 | 360035 | 0.090 |
Why?
|
| Brain Concussion | 1 | 2020 | 1403 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2017 | 1877 | 0.080 |
Why?
|
| Anesthesia | 1 | 2020 | 1588 | 0.080 |
Why?
|
| Electroencephalography | 3 | 2018 | 6215 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2017 | 1219 | 0.070 |
Why?
|
| Memory | 1 | 2017 | 2182 | 0.070 |
Why?
|
| Astrocytes | 1 | 2015 | 1345 | 0.070 |
Why?
|
| Gene Expression | 1 | 2019 | 7582 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 4413 | 0.060 |
Why?
|
| Mice | 5 | 2023 | 81402 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2017 | 3728 | 0.060 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 5764 | 0.060 |
Why?
|
| Brain | 3 | 2020 | 27060 | 0.050 |
Why?
|
| Anxiety | 1 | 2017 | 4558 | 0.050 |
Why?
|
| Hippocampus | 1 | 2014 | 3755 | 0.050 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 3702 | 0.050 |
Why?
|
| Dibenzazepines | 1 | 2020 | 26 | 0.040 |
Why?
|
| Vigabatrin | 1 | 2020 | 88 | 0.040 |
Why?
|
| Pyrrolidinones | 1 | 2020 | 116 | 0.040 |
Why?
|
| Functional Laterality | 2 | 2017 | 2253 | 0.040 |
Why?
|
| Humans | 9 | 2023 | 760437 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.040 |
Why?
|
| Losartan | 1 | 2020 | 265 | 0.040 |
Why?
|
| Otx Transcription Factors | 1 | 2017 | 42 | 0.040 |
Why?
|
| Drug Repositioning | 1 | 2020 | 233 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 41366 | 0.040 |
Why?
|
| Grooming | 1 | 2017 | 38 | 0.040 |
Why?
|
| Pentylenetetrazole | 1 | 2017 | 71 | 0.040 |
Why?
|
| Telemetry | 1 | 2018 | 199 | 0.040 |
Why?
|
| Convulsants | 1 | 2017 | 70 | 0.040 |
Why?
|
| Isoflurane | 1 | 2020 | 384 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 22121 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 54339 | 0.030 |
Why?
|
| Neurons | 1 | 2015 | 9443 | 0.030 |
Why?
|
| Maze Learning | 1 | 2017 | 482 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2020 | 719 | 0.030 |
Why?
|
| Lateral Ventricles | 1 | 2016 | 146 | 0.030 |
Why?
|
| Female | 6 | 2020 | 391875 | 0.030 |
Why?
|
| Dizocilpine Maleate | 1 | 2014 | 172 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 2058 | 0.030 |
Why?
|
| Video Recording | 1 | 2018 | 962 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 2803 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2015 | 301 | 0.030 |
Why?
|
| Sirolimus | 1 | 2020 | 1533 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 1844 | 0.030 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2014 | 448 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 1134 | 0.020 |
Why?
|
| Wakefulness | 1 | 2018 | 1265 | 0.020 |
Why?
|
| Liposomes | 1 | 2015 | 781 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14397 | 0.020 |
Why?
|
| Hypertension | 1 | 2010 | 8527 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2016 | 12785 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 544 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 1725 | 0.020 |
Why?
|
| Pakistan | 1 | 2010 | 293 | 0.020 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 1436 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 894 | 0.020 |
Why?
|
| Cadherins | 1 | 2013 | 904 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 220781 | 0.020 |
Why?
|
| beta Catenin | 1 | 2013 | 1040 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 10759 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 9533 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 4614 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5198 | 0.010 |
Why?
|
| Acute Disease | 1 | 2014 | 7230 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3541 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2047 | 0.010 |
Why?
|
| Sleep | 1 | 2018 | 4760 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2013 | 8311 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13484 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7597 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2010 | 2603 | 0.010 |
Why?
|
| Inflammation | 1 | 2020 | 10746 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20078 | 0.010 |
Why?
|
| Stroke | 1 | 2020 | 9745 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2010 | 4674 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2016 | 23397 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 39947 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 36183 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 42209 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 26063 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2013 | 64591 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 59068 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15476 | 0.000 |
Why?
|
| Child | 1 | 2013 | 80086 | 0.000 |
Why?
|
| Adolescent | 1 | 2013 | 88196 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 74055 | 0.000 |
Why?
|
| Aged | 1 | 2010 | 168840 | 0.000 |
Why?
|
| Middle Aged | 1 | 2010 | 220382 | 0.000 |
Why?
|